Cystic fibrosis: screening for a DNA deletion by field inversion gel electrophoresis

1988 ◽  
Vol 79 (1) ◽  
pp. 64-67 ◽  
Author(s):  
J. Morreau ◽  
M. Sinaasappel ◽  
B. A. Oostra ◽  
D. J. J. Halley
Keyword(s):  
Cystic Fibrosis ◽  
Gel Electrophoresis ◽  
Dna Deletion ◽  
Cystic Fibrosis Screening ◽  
Field Inversion

Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients

1996 ◽  
Vol 12 (2) ◽  
pp. 149-153
Author(s):  
G. Amalfitano ◽  
E. Tonolli ◽  
F. Favari ◽  
C. Perazzoli ◽  
G. Cazzola ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Gel Electrophoresis ◽  
Pseudomonas Cepacia ◽  
Field Inversion

Neonatal cystic fibrosis screening program in the state of Paraná: evaluation 30 months after implementation

10.2223/1345 ◽  
2005 ◽  
Vol 81 (3) ◽  
pp. 240-244
Author(s):  
Grégor P. Chermikoski Santos ◽  
Mouseline T. Domingos ◽  
Ehrenfried O. Wittig ◽  
Carlos A. Riedi ◽  
Nelson A. Rosário
Keyword(s):  
Cystic Fibrosis ◽  
Screening Program ◽  
The State ◽  
Cystic Fibrosis Screening

scholarly journals PP-15 CYSTIC FIBROSIS SCREENING TO OPTIMISE EGG AND SPERM DONOR SELECTION

2012 ◽  
Vol 24 ◽  
pp. S10-S11
Author(s):  
Silvia Modamio-Høybjør ◽  
Silvia Fernández ◽  
Raquel Garcia ◽  
Moisés De La Casa ◽  
Ferran Garcia ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Donor Selection ◽  
Sperm Donor ◽  
Cystic Fibrosis Screening

Optimal Genetic Screening for Cystic Fibrosis

2021 ◽  
Author(s):  
Hussein El Hajj ◽  
Douglas R. Bish ◽  
Ebru K. Bish
Keyword(s):  
Cystic Fibrosis ◽  
Genetic Variants ◽  
Genetic Screening ◽  
Genetic Diseases ◽  
The United States ◽  
Published Data ◽  
Decision Support Model ◽  
Screening Process ◽  
Public Health Initiative ◽  
Cystic Fibrosis Screening

Improving Newborn Screening for Genetic Diseases Screening newborns for life-threatening genetic diseases is an important public health initiative. Cystic fibrosis is one of the most prevalent diseases in this context. As part of the cystic fibrosis screening process, all states in the United States use multiple tests, including genetic tests that detect a subset of the more than 300 genetic variants (specific mutations) that cause cystic fibrosis. In “Optimal Genetic Screening for Cystic Fibrosis,” El-Hajj, D.R. Bish, and E.K. Bish develop a decision support model to select which genetic variants to screen for, considering the trade-off between classification accuracy and testing cost, and the technological constraints that limit the number of variants selected. Because variant prevalence rates are highly uncertain, a robust optimization framework is developed. Further, two commonly used cystic fibrosis screening processes are analytically compared, and conditions under which each process dominates are established. A case study based on published data are provided.

Cystic Fibrosis Screening

2005 ◽  
Vol 50 (3) ◽  
pp. 205-210 ◽  
Author(s):  
Lee P. Shulman
Keyword(s):  
Cystic Fibrosis ◽  
Cystic Fibrosis Screening

Challenges in Implementing a Successful Newborn Cystic Fibrosis Screening Program

2005 ◽  
Vol 147 (3) ◽  
pp. S89-S93 ◽  
Author(s):  
Anne Marie Comeau ◽  
Richard Parad ◽  
Robert Gerstle ◽  
Brian P. O'Sullivan ◽  
Henry L. Dorkin ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Screening Program ◽  
Cystic Fibrosis Screening

scholarly journals Analysis and Isolation of Cytomegalovirus DNA by Field Inversion Gel Electrophoresis

1988 ◽  
Vol 69 (3) ◽  
pp. 699-704 ◽  
Author(s):  
F. M. Van Den Berg ◽  
M. Jiwa ◽  
R. Rook ◽  
J. L. M. C. Geelen
Keyword(s):  
Gel Electrophoresis ◽  
Field Inversion
Sign in / Sign up

Export Citation Format

Share Document